Skip to main content

Immunome Inc.

IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001472012

In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 8 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Immunome Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
24
−2 vs. Q2 2022
Shares held
2.39M
−13.8K (−0.6%) vs. Q2 2022
Total value
$10.7M
+$2.95M (+37.9%) vs. Q2 2022
New holders
2
6 more added
Sold out
4
2 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IMNM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 24 institutions
Q1 2021: 31 institutionsQ2 2021: 29 institutionsQ3 2021: 35 institutionsQ4 2021: 30 institutionsQ1 2022: 29 institutionsQ2 2022: 26 institutionsQ3 2022: 24 institutionsQ4 2022: 28 institutionsQ1 2023: 30 institutionsQ2 2023: 35 institutionsQ3 2023: 35 institutionsQ4 2023: 57 institutionsQ1 2024: 103 institutionsQ2 2024: 114 institutionsQ3 2024: 115 institutionsQ4 2024: 121 institutionsQ1 2025: 143 institutionsQ2 2025: 142 institutionsQ3 2025: 153 institutionsQ4 2025: 183 institutionsQ1 2026: 202 institutionsQ2 2026: 202 institutions
Value heldQ3 2022: $10.7M
Q1 2021: $64.7MQ2 2021: $41.1MQ3 2021: $58.3MQ4 2021: $36.4MQ1 2022: $15.4MQ2 2022: $7.78MQ3 2022: $10.7MQ4 2022: $4.85MQ1 2023: $9.34MQ2 2023: $15.4MQ3 2023: $19.7MQ4 2023: $229.9MQ1 2024: $903.6MQ2 2024: $578.4MQ3 2024: $754.7MQ4 2024: $566.3MQ1 2025: $518.4MQ2 2025: $738.7MQ3 2025: $1.07BQ4 2025: $2.54BQ1 2026: $2.54BQ2 2026: $2.50B
Institutions holding IMNM and their total value by quarter
QuarterHoldersValue
Q2 2026202$2.50B
Q1 2026202$2.54B
Q4 2025183$2.54B
Q3 2025153$1.07B
Q2 2025142$738.7M
Q1 2025143$518.4M
Q4 2024121$566.3M
Q3 2024115$754.7M
Q2 2024114$578.4M
Q1 2024103$903.6M
Q4 202357$229.9M
Q3 202335$19.7M
Q2 202335$15.4M
Q1 202330$9.34M
Q4 202228$4.85M
Q3 202224$10.7M
Q2 202226$7.78M
Q1 202229$15.4M
Q4 202130$36.4M
Q3 202135$58.3M
Q2 202129$41.1M
Q1 202131$64.7M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Immunome Inc.; share changes are against Q2 2022.

Institutions holding IMNM in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Prentice Capital Management, LP791,821$3.52M2.61%00.0%Unchanged
Alpine Global Management, LLC718,235$3.19M0.75%00.0%Unchanged
Vanguard Group Inc373,685$1.66M0.00%+3,149+0.8%Added
Bank of Montreal92,593$529.0K0.00%00.0%Unchanged
Geode Capital Management, LLC81,406$361.0K0.00%00.0%Unchanged
Cerity Partners LLC56,962$253.0K0.00%00.0%Unchanged
BlackRock Inc.41,452$183.0K0.00%+2,241+5.7%Added
State Street Corp29,591$131.0K0.00%00.0%Unchanged
Royal Bank of Canada28,495$126.0K0.00%+116+0.4%Added
Magnus Financial Group LLC25,759$114.0K0.02%00.0%Unchanged
Baldwin Investment Management, LLC25,394$113.0K0.04%00.0%Unchanged
Sterling Investment Advisors, Ltd.21,627$96.0K0.04%00.0%Unchanged
Renaissance Technologies LLC21,500$95.0K0.00%00.0%Unchanged
Neuberger Berman Group LLC19,444$86.0K0.00%00.0%Unchanged
Northern Trust Corp16,798$75.0K0.00%00.0%Unchanged
UBS Group AG15,271$68.0K0.00%+13,943+1,049.9%Added
Morgan Stanley12,134$53.0K0.00%−796−6.2%Reduced
Wealth Architects, LLC11,110$49.0K0.01%00.0%Unchanged
Simplex Trading, LLC3,642$16.0K0.00%+1,679+85.5%Added
Group One Trading, L.P.2,276$10.0K0.00%+2,228+4,641.7%Added
Wells Fargo & Company1,851$8.00K0.00%−1−0.1%Reduced
Advisor Group Holdings, Inc.1,229$5.00K0.00%+1,229New
Newbridge Financial Services Group, Inc.375$2.00K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA67$2970.00%+67New
Citadel Advisors LLC0$00.00%−13,159−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−12,052−100.0%Sold out
Titleist Asset Management, Ltd.0$00.00%−10,000−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−2,489−100.0%Sold out